Prosecution Insights
Prosecution Insights
1 pending office actions • 0 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Mee-Hu Pharma GmbH is currently managing 1 pending office action. This prosecution activity involves 1 distinct examiner, KRISHNAN, GANAPATHY, who is the busiest examiner for the company. The data shows 0 distinct art units associated with this activity. With the pending office action and the examiner involved, the company's immediate administrative burden is limited.
The active matter represents the entirety of the current workload. Practitioners should note that the distinct examiner is the sole point of contact for the company's active prosecution. The presence of 0 distinct art units in the record for the pending office action may require clarification during the prosecution process. This focused profile allows the company to dedicate its attention to the specific requirements of KRISHNAN, GANAPATHY. The legal team can prioritize the response to this active case. This streamlined engagement suggests a very specific technical or procedural stage for the company.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KRISHNAN, GANAPATHY | 1 | 52.7% | +1.3% |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18722070 | MEDICINAL COMPOSITION COMPRISING RIBOSE AND AMINO ACIDS | KRISHNAN, GANAPATHY | — | §103 | Non-Final OA | — | Pending | Jun 20, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialMee-Hu Pharma GmbH has 1 pending office actions as of October 2026, spread across 0 art units and 1 examiners.
Ganapathy Krishnan has the most, with 1 of Mee-Hu Pharma GmbH's pending office actions.